| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/04/2003 | US20030166875 Fibroblast growth factor homologous factor-2 and methods of use |
| 09/04/2003 | US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 09/04/2003 | US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents |
| 09/04/2003 | US20030166853 Mucin peptide with immunoenhancing properties |
| 09/04/2003 | US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound |
| 09/04/2003 | US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
| 09/04/2003 | US20030166847 Novel human leptin receptor gene-related protein |
| 09/04/2003 | US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 09/04/2003 | US20030166837 Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof |
| 09/04/2003 | US20030166727 Antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 09/04/2003 | US20030166713 Photodynamid therapy |
| 09/04/2003 | US20030166710 A cylic peroxide containing methyl carboxylic acid or ester; anticarcinogenic agent |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166683 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 09/04/2003 | US20030166674 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 09/04/2003 | US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation |
| 09/04/2003 | US20030166658 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/04/2003 | US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 09/04/2003 | US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166642 Administering synergistic mixtures of phenothiazine and pentamidine derivatives as anticarcinogenic agents |
| 09/04/2003 | US20030166630 Amino acid derivatives and their use as medicines |
| 09/04/2003 | US20030166628 Drugs such as 3-(4-chlorobenzo(b)thiophen-2-yl)-5,6-dihydro-imidazo(2,1-b)thiazole, used as hydroxytryptamine and/or noradrenaline reuptake inhibitors; anxiolytic agents |
| 09/04/2003 | US20030166622 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents |
| 09/04/2003 | US20030166617 Combination therapies with vascular damaging activity |
| 09/04/2003 | US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds |
| 09/04/2003 | US20030166609 Medicine containing polysacccharide substances for activating apoptosis |
| 09/04/2003 | US20030166603 Using a p53- expressing viral vector as anticarcinogenic agents |
| 09/04/2003 | US20030166599 Uses of tgap7 for the modulation of leucocyte activation |
| 09/04/2003 | US20030166598 Such as 1,4-benzodiazipines; gene therapy; anticancer agents |
| 09/04/2003 | US20030166588 Splice-region antisense composition and method |
| 09/04/2003 | US20030166587 Compounds and methods for modulating activation of NF-kB |
| 09/04/2003 | US20030166576 Urokinase inhibitors |
| 09/04/2003 | US20030166572 2-Amino-3-hydroxy-4-tert-leucyl-amino-5 phenyl-pentanoic acid amide derivatives |
| 09/04/2003 | US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/04/2003 | US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions |
| 09/04/2003 | US20030166556 Immunoregulator |
| 09/04/2003 | US20030166546 Uses of THANK, a TNF homologue that activates apoptosis |
| 09/04/2003 | US20030166543 Functional antagonists of hedgehog activity |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/04/2003 | US20030166524 Therapeutic uses of IL-1 receptor antagonist |
| 09/04/2003 | US20030166513 Dds compound and process for the preparation thereof |
| 09/04/2003 | US20030166300 Growth-related inflammatory and immune response protein |
| 09/04/2003 | US20030166283 Drug screening a modulator as antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; genetic engineering, receptor binding assay, gene expression |
| 09/04/2003 | US20030166257 Use of Lactobacillus salivarius |
| 09/04/2003 | US20030166253 A simple and efficient method of producing mammalian reovirus is developed using HEK 293 cells. The method provides for fast production of reovirus in high yield. Furthermore, this method provides for a simpler purification procedure of the |
| 09/04/2003 | US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells |
| 09/04/2003 | US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK) |
| 09/04/2003 | US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases |
| 09/04/2003 | US20030166164 IL-17 like molecules and uses thereof |
| 09/04/2003 | US20030166163 Immunocytokines with modulated selectivity |
| 09/04/2003 | US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2003 | US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all |
| 09/04/2003 | US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 09/04/2003 | US20030166044 Novel proteins |
| 09/04/2003 | US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases |
| 09/04/2003 | US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy |
| 09/04/2003 | US20030165930 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof |
| 09/04/2003 | US20030165892 Unigene unidirectional antisense library |
| 09/04/2003 | US20030165878 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 09/04/2003 | US20030165831 Comprise nucleotide sequences for diagnosing and treating gynecological tumors; antitumor/anticarcinogenic agents |
| 09/04/2003 | US20030165809 MARKs as modifiers of the p53 pathway and methods of use |
| 09/04/2003 | US20030165576 Antitumor effect potentiators |
| 09/04/2003 | US20030165519 Administering complex of protein taken from original tumor |
| 09/04/2003 | US20030165512 Composition of antigen and glycolipid adjuvant for sublingual administration |
| 09/04/2003 | US20030165510 Antiinflammatory agents; anticancer agents; cholesterol binding protein |
| 09/04/2003 | US20030165506 Novel alpha-catenin expressed in heart and testis |
| 09/04/2003 | US20030165499 Compositions and methods for treating psoriasis |
| 09/04/2003 | US20030165497 RRP sequences and knockout mice and uses thereof |
| 09/04/2003 | US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering |
| 09/04/2003 | US20030165490 22196, a novel human aminopeptidase |
| 09/04/2003 | US20030165478 Stabilized synthetic immunogen delivery system |
| 09/04/2003 | US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents |
| 09/04/2003 | US20030165459 Binding to tumor necrosis factor |
| 09/04/2003 | US20030165434 Delivery of polynucleotide agents to the central nervous system |
| 09/04/2003 | US20030165432 Versatile hydrophilic dyes |
| 09/04/2003 | US20030165426 Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy |
| 09/04/2003 | CA2833470A1 Processes for preparing form 1 zd1839 polymorph |
| 09/04/2003 | CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
| 09/04/2003 | CA2702297A1 Novel crystalline forms of the anti-cancer compound zd1839 |
| 09/04/2003 | CA2662899A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 09/04/2003 | CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 09/04/2003 | CA2503094A1 Therapeutic methods for acute myeloid leukemia |
| 09/04/2003 | CA2480408A1 A method for encapsulating metal complex in liposomes |
| 09/04/2003 | CA2479812A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 09/04/2003 | CA2477417A1 Methods and products based on oligomerization of stress proteins |
| 09/04/2003 | CA2477350A1 Novel crystalline forms of the anti-cancer compound zd1839 |
| 09/04/2003 | CA2477328A1 Pyridyl tricyclic compounds as farnesyl protein transferase inhibitors and antitumor agents |
| 09/04/2003 | CA2477283A1 Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes |
| 09/04/2003 | CA2477253A1 Compositions and method for regulation of calcium-dependent signalling in brain |
| 09/04/2003 | CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |